Replies to post #230608 on Biotech Values

[DewDiligence]

VIR—The answers to some of those questions will likely remain trade secrets for a little while.

[DewDiligence]

VIR -10%—perhaps some investors were hoping VIR/GSK would be a finalist in Operation Warp Speed (#msg-156027500).

Such an outcome was never in the cards because the VIR/GSK collaboration is mostly about COVID-19 antibodies rather than vaccines (https://www.globenewswire.com/news-release/2020/04/06/2012095/0/en/GSK-and-Vir-Biotechnology-enter-collaboration-to-find-coronavirus-solutions.html ).

[DewDiligence]

Are you still long VIR?